Cadence Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.18M Buy
17,752
+18
+0.1% +$2.19K 0.13% 112
2025
Q3
$1.97M Buy
17,734
+268
+2% +$30.5K 0.12% 123
2025
Q2
$1.94M Buy
17,466
+9,225
+112% +$982K 0.13% 120
2025
Q1
$923K Buy
8,241
+139
+2% +$14.3K 0.07% 164
2024
Q4
$748K Sell
8,102
-114,867
-93% -$10.3M 0.05% 184
2024
Q3
$10.3M Buy
122,969
+3,800
+3% +$290K 0.71% 31
2024
Q2
$8.18M Buy
119,169
+1,826
+2% +$122K 0.61% 34
2024
Q1
$8.6M Sell
117,343
-193
-0.2% -$14.8K 0.63% 37
2023
Q4
$9.52M Buy
117,536
+542
+0.5% +$42.2K 0.77% 29
2023
Q3
$8.77M Sell
116,994
-16
-0% -$1.23K 0.77% 31
2023
Q2
$9.02M Buy
117,010
+4,034
+4% +$322K 0.79% 27
2023
Q1
$9.37M Sell
112,976
-1,104
-1% -$91.4K 0.86% 25
2022
Q4
$9.79M Buy
114,080
+348
+0.3% +$27.6K 0.9% 23
2022
Q3
$7.02M Buy
113,732
+3,550
+3% +$224K 0.73% 29
2022
Q2
$6.81M Buy
110,182
+3,607
+3% +$223K 0.98% 31
2022
Q1
$6.34M Buy
+106,575
New +$6.81M 0.79% 40
2020
Q2
Sell
-3,303
Closed -$247K 185
2020
Q1
$247K Sell
3,303
-51,644
-94% -$3.57M 0.06% 154
2019
Q4
$3.57M Buy
+54,947
New +$3.58M 0.66% 46
2018
Q1
Sell
-46,033
Closed -$3.3M 249
2017
Q4
$3.3M Buy
+46,033
New +$3.5M 0.31% 45

Other funds holding GILD

Cadence Bank's GILD Position: Q4 2025 in Review

Cadence Bank increased its Gilead Sciences (GILD) stake by 0.1% in Q4 2025, buying an estimated $2.19K and bringing the position to 17,752 shares worth $2.18M. The position accounts for 0.13% of the portfolio, ranked #112.

Cadence Bank first reported a position in GILD in Q4 2017 and has held it in 19 quarters since. The position peaked at $10.3M in Q3 2024. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Cadence Bank held 17,752 shares of Gilead Sciences worth $2.18M as of Q4 2025.
  • Cadence Bank bought 18 Gilead Sciences shares in Q4 2025, an estimated $2.19K.
  • Gilead Sciences made up 0.13% of Cadence Bank's portfolio in Q4 2025, its #112 holding.
  • Cadence Bank first reported a position in Gilead Sciences in Q4 2017 and has held it in 19 quarters since.
  • Cadence Bank's Gilead Sciences position peaked at $10.3M in Q3 2024.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Cadence Bank's 13F filing for Q4 2025, filed 30 Jan 2026.